BKS Advisors’s Elevance Health ELV Stock Holding History

BKS Advisors’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-4,465	Closed	-$621K	–	177
2016 Q1	$621K	Buy	+4,465	New	+$597K	0.32%	81

Other funds holding ELV

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

BKS Advisors's ELV Position: Q2 2016 in Review

BKS Advisors sold out of Elevance Health (ELV) in Q2 2016, closing a stake of 4,465 shares — an estimated $621K sold.

BKS Advisors first reported a position in ELV in Q1 2016 and held it in 1 quarter. The position peaked at $621K in Q1 2016. 759 funds tracked by Wall St. Rank hold ELV as of Q2 2016.

BKS Advisors reported no remaining Elevance Health position as of Q2 2016 after selling out during the quarter.
BKS Advisors sold 4,465 Elevance Health shares in Q2 2016, an estimated $621K.
BKS Advisors first reported a position in Elevance Health in Q1 2016 and held it in 1 quarter.
BKS Advisors's Elevance Health position peaked at $621K in Q1 2016.
759 funds tracked by Wall St. Rank held Elevance Health as of Q2 2016.

Based on BKS Advisors's 13F filing for Q2 2016, filed 9 Aug 2016.